Nilotinib (200mg) - Dosage Form: Hard Gelatin Capsule

89.23

1 Strip/Strips

1 Pack/Packs

100 Pack/Packs

INDIA

India

Chronic Myeloid Leukemia (CML)

Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

NILOTHERAPY 200 is a high-quality pharmaceutical formulation containing Nilotinib (200mg), a targeted anti-cancer medication primarily used in the management of certain types of blood cancer. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking abnormal proteins that signal cancer cells to grow and multiply.This medicine is widely prescribed for patients diagnosed with chronic myeloid leukemia (CML), especially those who are newly diagnosed or those who cannot tolerate other treatments. NILOTHERAPY 200 is designed to offer precise and effective therapy, helping improve patient outcomes with a well-established safety profile when used under medical supervision.UsesNILOTHERAPY 200 (Nilotinib 200mg) is mainly indicated for:Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)Management of newly diagnosed adult patients with chronic phase CMLTreatment of patients resistant or intolerant to prior therapies like imatinibLong-term control of leukemia progressionIt is a prescription-only medication and should be used strictly under the guidance of an oncologist.BenefitsNILOTHERAPY 200 offers several clinically proven benefits in leukemia treatment:Targeted Cancer Therapy: Specifically blocks abnormal BCR-ABL protein responsible for cancer cell growthEffective Disease Control: Helps reduce cancer cell count and slows disease progressionImproved Survival Rates: Supports long-term remission in many patientsBetter Tolerability: Compared to traditional chemotherapy, it has a more targeted action with fewer generalized side effectsOral Convenience: Available in capsule form, making it easy for patients to follow treatment at homeWith consistent use, NILOTHERAPY 200 can significantly improve quality of life in patients with CML.DosageThe dosage of NILOTHERAPY 200 should always be determined by a healthcare professional based on the patient s condition and response to therapy.General dosage guidelines:Typically taken twice daily (every 12 hours)Should be taken on an empty stomach (at least 2 hours after food and 1 hour before the next meal)Capsules should be swallowed whole with waterImportant instructions:Do not skip doses or stop treatment without consulting your doctorRegular blood tests and monitoring are essential during therapySide EffectsLike all medications, NILOTHERAPY 200 (Nilotinib 200mg) may cause some side effects. Most are manageable and may reduce over time.Common side effects:Nausea and vomitingHeadacheFatigueSkin rash or itchingConstipation or diarrheaSerious side effects (seek medical attention):Irregular heartbeat (QT prolongation)Severe liver problemsPancreatitisSudden weight gain or swellingLow blood cell countsPatients should report any unusual symptoms to their doctor immediately.Precautions and WarningBefore starting NILOTHERAPY 200, certain precautions should be considered to ensure safe use:Heart Conditions: Patients with a history of heart disease or irregular heartbeat should use with cautionLiver Disorders: Dose adjustments may be required in patients with liver impairmentPregnancy and Breastfeeding: Not recommended during pregnancy or lactation unless clearly advised by a doctorDrug Interactions: Avoid use with certain medications like anti-arrhythmics, antifungals, and antibiotics without medical consultationElectrolyte Imbalance: Ensure proper monitoring of potassium and magnesium levelsAvoid Grapefruit: Grapefruit and its juice may interfere with drug metabolismRegular monitoring and strict adherence to medical advice are crucial for safe and effective treatment.ConclusionNILOTHERAPY 200, containing Nilotinib (200mg), is a trusted and advanced treatment option for patients suffering from chronic myeloid leukemia. Its targeted mechanism of action helps control disease progression while minimizing damage to healthy cells. With proper dosage, monitoring, and medical supervision, NILOTHERAPY 200 plays a vital role in improving survival outcomes and enhancing the quality of life for cancer patients.

Nilotinib

Nilotinib

200 mg

As Directed by the Physician

200 Mg

Store at 25 C (77 F); excursions permitted to 15 30 C

Store below 30AdegC

Store below 30 DegreeC

Others, Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Cash in Advance (CID)

Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Eastern Europe, North America, South America, Africa, Central America, Western Europe, Middle East, Asia, Australia